The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
West Midlands tender, Dibs mentioned 18 Feb:
https://bidstats.uk/tenders/2023/W06/792461339
The Authority will hold a “supplier day” briefing session on the 14th of March 2023, in Birmingham, to which interested suppliers are invited.
I got there eventually!
https://www.investormeetcompany.com/investor/meeting/results-and-company-update-17
Certainly one to win! Non-CDC contracts question at the presentation - I thought Tom was cautious in his reply, and wanted to maintain focus on CDCs. Let's hope he was downplaying it. Good luck to Tom and the team.
Welloil/Dibs, it's certainly true of my GP surgery. They have taken on more patients from two closed surgeries. Non-urgent GP appointments are a four week wait. It certainly won't be one surgery! Bleepa will help, but a reset and fresh start is definitely required, otherwise those beaches in New South Wales will be more than tempting.
It is dependent on GP access, certainly. If on an ' urgent' pathway, like dodgy prostate results, then it can be reasonably quick. But for chronic symptoms it could well be delayed. Regional variations. This is where .gov need to wake up. Where are the staff? Now seeing adverts encouraging medical staff to Australia, not that new but seem more prevalent. Hopefully Bleepa will transform the care pathway, and .gov will wake up.